Common use of Vertex’s Termination for Convenience Clause in Contracts

Vertex’s Termination for Convenience. Vertex will be entitled to terminate this Agreement as a whole, or terminate this Agreement in part with respect to a particular Collaboration Program, for convenience by providing CRISPR 90 days’ written notice of such termination; provided, however, that if any termination under this Section 11.2.1 applies to a Product for which Vertex has received Marketing Approval, Vertex will provide CRISPR no less than 270 days’ notice of such termination.

Appears in 4 contracts

Samples: Strategic Collaboration, Option and License Agreement, Strategic Collaboration, Option and License Agreement (CRISPR Therapeutics AG), Strategic Collaboration, Option and License Agreement (CRISPR Therapeutics AG)

AutoNDA by SimpleDocs

Vertex’s Termination for Convenience. Vertex will be entitled to terminate this Agreement as a wholefor convenience, in its entirety or terminate this Agreement in part with respect to a particular Collaboration Programone or more Shared Product(s), for convenience by providing CRISPR 90 days’ written notice of such termination; provided, however, that if any termination under this Section 11.2.1 applies 17.2.1 with respect to a Shared Product for which Vertex occurs after such Shared Product has received Marketing Approval, Vertex will provide CRISPR no less than 270 days’ written notice of such termination.

Appears in 2 contracts

Samples: Joint Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), Joint Development and Commercialization Agreement (CRISPR Therapeutics AG)

AutoNDA by SimpleDocs

Vertex’s Termination for Convenience. Vertex will be entitled to terminate this Agreement as a wholefor convenience, in its entirety or terminate this Agreement in part with respect to a particular Collaboration Programone or more Shared Product(s), for convenience by providing CRISPR 90 days’ written notice of such termination; provided, however, that if any termination under this Section 11.2.1 applies 14.2.1 with respect to a Shared Product for which Vertex occurs after such Shared Product has received Marketing Approval, Vertex will provide CRISPR no less than 270 days’ written notice of such termination.

Appears in 1 contract

Samples: Joint Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!